Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Emmaus Life Sciences Inc (OTCQX:EMMA) announced that it has received a Medicine Registration Certificate (DRN-10164/23) from the Bahrain National Health.
TORRANCE, Calif., May 31, 2023 /PRNewswire/ Emmaus Life Sciences, Inc. , a leader in sickle cell disease treatment, announced today that it has received a Medicine Registration. | June 7, 2023